Average Insider

Where insiders trade, we follow

Insider Buy/Sell Ratio — Last 30 Days

Showing all data including statistical outliers.Hide Outliers
Ratio0.3:1
Daily Buy & Sell Volume

By Sector

By Industry

Oil & Gas Exploration & Production
Buys39
Sells19
Buy $$3.90M
Sell $$3.78B
Ratio1:967.11
Computer Hardware
Buys2
Sells991
Buy $$9.90K
Sell $$1.23B
Ratio1:124374.07
% Change vs. Prior
Ratio +inf%Value +25.7%
Semiconductors
Buys35
Sells208
Buy $$468.61K
Sell $$908.54M
Ratio1:1938.80
% Change vs. Prior
Ratio -95.1%Value -13.9%
Biotechnology
Buys194
Sells876
Buy $$191.45M
Sell $$589.14M
Ratio1:3.08
% Change vs. Prior
Ratio +205.9%Value -28.0%
Software - Application
Buys63
Sells480
Buy $$47.62M
Sell $$717.26M
Ratio1:15.06
% Change vs. Prior
Ratio +81.5%Value -8.1%
Software - Infrastructure
Buys25
Sells672
Buy $$4.51M
Sell $$723.00M
Ratio1:160.26
% Change vs. Prior
Ratio -30.4%Value -50.8%
Information Technology Services
Buys31
Sells47
Buy $$9.20M
Sell $$606.79M
Ratio1:65.96
Medical - Care Facilities
Buys1
Sells16
Buy $$416.33
Sell $$422.53M
Ratio1:1014888.91
% Change vs. Prior
Ratio -99.8%Value -46.0%
Residential Construction
Buys31
Sells1
Buy $$402.78M
Sell $$108.79K
Ratio3702.31:1
Banks - Regional
Buys94
Sells209
Buy $$5.52M
Sell $$371.25M
Ratio1:67.27
% Change vs. Prior
Ratio +36.5%Value -62.7%
Waste Management
Buys17
Sells1
Buy $$370.36M
Sell $$300.16K
Ratio1233.86:1
% Change vs. Prior
Ratio +304.7%Value -63.7%
Medical - Diagnostics & Research
Buys2
Sells186
Buy $$7.82K
Sell $$302.71M
Ratio1:38714.01
% Change vs. Prior
Ratio -99.4%Value -58.0%
Asset Management
Buys126
Sells72
Buy $$191.73M
Sell $$74.46M
Ratio2.57:1
% Change vs. Prior
Ratio +8543.8%Value -57.5%
Specialty Retail
Buys35
Sells225
Buy $$82.71M
Sell $$152.24M
Ratio1:1.84
% Change vs. Prior
Ratio +1246.5%Value -71.7%
Auto - Dealerships
Buys100
Sells5
Buy $$156.56M
Sell $$1.68M
Ratio93.27:1
Oct 2, 2026
Sale
Shares
93
Price
$106.36
Total Value
$9.89K
Shares Held After
423,029
% of Holdings
0.0%
Oct 2, 2026
Sale
Shares
1,334
Price
$105.66
Total Value
$140.96K
Shares Held After
423,122
% of Holdings
0.3%
Oct 2, 2026
Sale
Shares
470
Price
$104.40
Total Value
$49.07K
Shares Held After
424,456
% of Holdings
0.1%
Oct 2, 2026
Sale
Shares
1,124
Price
$103.53
Total Value
$116.36K
Shares Held After
424,926
% of Holdings
0.3%
Oct 2, 2026
Sale
Shares
1,068
Price
$102.38
Total Value
$109.35K
Shares Held After
426,050
% of Holdings
0.3%
Oct 2, 2026
Sale
Shares
1,632
Price
$101.39
Total Value
$165.47K
Shares Held After
427,118
% of Holdings
0.4%

Xometry, Inc. (XMTR)

Raghavan Vaidyanathan — Chief Technology Officer
Oct 2, 2026
Sale
Shares
317
Price
$105.76
Total Value
$33.52K
Shares Held After
133,911
% of Holdings
0.2%

Xometry, Inc. (XMTR)

Raghavan Vaidyanathan — Chief Technology Officer
Oct 2, 2026
Sale
Shares
284
Price
$104.90
Total Value
$29.79K
Shares Held After
134,228
% of Holdings
0.2%

Xometry, Inc. (XMTR)

Raghavan Vaidyanathan — Chief Technology Officer
Oct 2, 2026
Sale
Shares
373
Price
$103.53
Total Value
$38.62K
Shares Held After
134,512
% of Holdings
0.3%

Xometry, Inc. (XMTR)

Raghavan Vaidyanathan — Chief Technology Officer
Oct 2, 2026
Sale
Shares
343
Price
$102.38
Total Value
$35.11K
Shares Held After
134,885
% of Holdings
0.3%

Xometry, Inc. (XMTR)

Raghavan Vaidyanathan — Chief Technology Officer
Oct 2, 2026
Sale
Shares
549
Price
$101.41
Total Value
$55.67K
Shares Held After
135,228
% of Holdings
0.4%
Oct 2, 2026
Sale
Shares
32
Price
$106.28
Total Value
$3.40K
Shares Held After
179,791
% of Holdings
0.0%
Oct 2, 2026
Sale
Shares
264
Price
$105.45
Total Value
$27.84K
Shares Held After
179,823
% of Holdings
0.1%
Oct 2, 2026
Sale
Shares
74
Price
$104.41
Total Value
$7.73K
Shares Held After
180,087
% of Holdings
0.0%
Oct 2, 2026
Sale
Shares
228
Price
$103.42
Total Value
$23.58K
Shares Held After
180,161
% of Holdings
0.1%
Oct 2, 2026
Sale
Shares
247
Price
$102.18
Total Value
$25.24K
Shares Held After
180,389
% of Holdings
0.1%
Oct 2, 2026
Sale
Shares
267
Price
$101.38
Total Value
$27.07K
Shares Held After
180,636
% of Holdings
0.1%
Oct 2, 2026
Sale
Shares
12,570
Price
$20.01
Total Value
$251.48K
Shares Held After
722,288
% of Holdings
1.7%
Oct 2, 2026
Sale
Shares
34,005
Price
$344.00
Total Value
$11.70M
Shares Held After
1,137,741
% of Holdings
2.9%
Oct 2, 2026
Sale
Shares
840
Price
$344.00
Total Value
$288.96K
Shares Held After
24,356
% of Holdings
3.3%
Oct 2, 2026
Sale
Shares
840
Price
$344.00
Total Value
$288.96K
Shares Held After
24,356
% of Holdings
3.3%
Oct 2, 2026
Sale
Shares
840
Price
$344.00
Total Value
$288.96K
Shares Held After
24,356
% of Holdings
3.3%
Oct 2, 2026
Sale
Shares
840
Price
$344.00
Total Value
$288.96K
Shares Held After
24,356
% of Holdings
3.3%
Oct 2, 2026
Sale
Shares
12,973
Price
$344.00
Total Value
$4.46M
Shares Held After
376,201
% of Holdings
3.3%
Oct 2, 2026
Sale
Shares
403
Price
$344.00
Total Value
$138.63K
Shares Held After
21,767
% of Holdings
1.8%
Oct 2, 2026
Purchase
Shares
10,000
Price
$4.09
Total Value
$40.90K
Shares Held After
4,565,000
% of Holdings
0.2%
Oct 2, 2026
Purchase
Shares
3,190
Price
$4.13
Total Value
$13.17K
Shares Held After
4,555,000
% of Holdings
0.1%

QUALCOMM INC/DE (QCOM)

Grech Patricia Y — SVP, Chief Accounting Officer
Oct 2, 2026
Sale
Shares
98
Price
$186.55
Total Value
$18.28K
Shares Held After
0
% of Holdings
100.0%
Oct 2, 2026
Sale
Shares
20,306
Price
$0.69
Total Value
$14.04K
Shares Held After
974,609
% of Holdings
2.0%

Alkermes plc. (ALKS)

Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Oct 2, 2026
Sale
Shares
2,034
Price
$41.03
Total Value
$83.46K
Shares Held After
221,388
% of Holdings
0.9%
Oct 2, 2026
Purchase
Shares
1,510
Price
$2.92
Total Value
$4.40K
Shares Held After
518,073
% of Holdings
0.3%
Oct 2, 2026
Purchase
Shares
867
Price
$2.90
Total Value
$2.52K
Shares Held After
518,073
% of Holdings
0.2%

Cardlytics, Inc. (CDLX)

Gupta Amit — Director
Oct 2, 2026
Sale
Shares
7,382
Price
$2.53
Total Value
$18.70K
Shares Held After
138,906
% of Holdings
5.0%

Stoke Therapeutics, Inc. (STOK)

Allan Jonathan — GENERAL COUNSEL&CORP SEC
Oct 2, 2026
Sale
Shares
627
Price
$26.33
Total Value
$16.51K
Shares Held After
20,598
% of Holdings
3.0%

Nurix Therapeutics, Inc. (NRIX)

Ring Christine — Chief Legal Officer
Oct 2, 2026
Sale
Shares
5,786
Price
$23.19
Total Value
$134.15K
Shares Held After
9,110
% of Holdings
38.8%

GameStop Corp. (GME)

Cohen Ryan — Director
Oct 2, 2026
Purchase
Shares
700,000
Price
$24.41
Total Value
$17.08M
Shares Held After
41,648,522
% of Holdings
1.7%
Oct 2, 2026
Sale
Shares
62,500
Price
$6.09
Total Value
$380.62K
Shares Held After
55,640,557
% of Holdings
0.1%

BioNTech SE (BNTX)

Sahin Ugur — Chief Executive Officer
Oct 2, 2026
Sale
Shares
17,000
Price
$96.72
Total Value
$1.64M
Shares Held After
180,209
% of Holdings
8.6%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Oct 1, 2026
Sale
Shares
1,846
Price
$415.07
Total Value
$766.22K
Shares Held After
106,914
% of Holdings
1.7%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Oct 1, 2026
Sale
Shares
954
Price
$413.11
Total Value
$394.10K
Shares Held After
108,760
% of Holdings
0.9%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Oct 1, 2026
Sale
Shares
200
Price
$411.62
Total Value
$82.32K
Shares Held After
109,714
% of Holdings
0.2%
Oct 1, 2026
Sale
Shares
1,273
Price
$413.31
Total Value
$526.14K
Shares Held After
96,926
% of Holdings
1.3%

Spyre Therapeutics, Inc. (SYRE)

King-Jones Heidy — Chief Legal Officer and Corporate Secretary
Oct 1, 2026
Sale
Shares
2,600
Price
$93.46
Total Value
$243.00K
Shares Held After
2,845
% of Holdings
47.8%

Spyre Therapeutics, Inc. (SYRE)

King-Jones Heidy — Chief Legal Officer and Corporate Secretary
Oct 1, 2026
Sale
Shares
2,100
Price
$92.70
Total Value
$194.67K
Shares Held After
5,445
% of Holdings
27.8%

Spyre Therapeutics, Inc. (SYRE)

King-Jones Heidy — Chief Legal Officer and Corporate Secretary
Oct 1, 2026
Sale
Shares
7,228
Price
$91.35
Total Value
$660.28K
Shares Held After
7,545
% of Holdings
48.9%

Spyre Therapeutics, Inc. (SYRE)

King-Jones Heidy — Chief Legal Officer and Corporate Secretary
Oct 1, 2026
Sale
Shares
16,605
Price
$90.35
Total Value
$1.50M
Shares Held After
14,773
% of Holdings
52.9%

Spyre Therapeutics, Inc. (SYRE)

King-Jones Heidy — Chief Legal Officer and Corporate Secretary
Oct 1, 2026
Sale
Shares
400
Price
$89.24
Total Value
$35.70K
Shares Held After
31,378
% of Holdings
1.3%

Spyre Therapeutics, Inc. (SYRE)

Burrows Scott L — Chief Financial Officer
Oct 1, 2026
Sale
Shares
229
Price
$93.57
Total Value
$21.43K
Shares Held After
79,762
% of Holdings
0.3%

Spyre Therapeutics, Inc. (SYRE)

Burrows Scott L — Chief Financial Officer
Oct 1, 2026
Sale
Shares
3,071
Price
$92.95
Total Value
$285.45K
Shares Held After
79,991
% of Holdings
3.7%

Spyre Therapeutics, Inc. (SYRE)

Burrows Scott L — Chief Financial Officer
Oct 1, 2026
Sale
Shares
2,100
Price
$91.92
Total Value
$193.03K
Shares Held After
83,062
% of Holdings
2.5%
Version: v26.10.2